Meeting
2020 ASCO Virtual Scientific Program
Venous thromboembolism prophylaxis in ambulatory cancer patients initiating chemotherapy: A cost-effectiveness analysis.
Authors
Emma Ryan
Duke University School of Medicine, Durham, NC
Emma Ryan , Julia Salinaro , Laura J Havrilesky , Brittany Anne Davidson
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Health Services Research and Quality Improvement
Track
Quality Care/Health Services Research
Sub Track
Value/Cost of Care
Citation
J Clin Oncol 38: 2020 (suppl; abstr 7074)
DOI
10.1200/JCO.2020.38.15_suppl.7074
Abstract #
7074
Poster Bd #
346
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
Evaluation of an oral direct anti-Xa anticoagulant, apixaban, for the prevention of venous thromboembolism in patients with myeloma treated with IMiD* compounds: A pilot study (MYELAXAT).
First Author: Brigitte Pegourie
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Bleeding and thrombotic events in patients with colorectal cancer treated with bevacizumab and receiving novel oral anticoagulants and antiplatelet medications.
First Author: Shinji Rho
Poster
2023 ASCO Quality Care Symposium
Impact of integrating standardized venous thromboembolism (VTE) prophylaxis orders for patients with multiple myeloma into an electronic health record (EHR).
First Author: Andrea Dickens
Poster
2023 ASCO Annual Meeting
Venous thromboembolism prophylaxis during neoadjuvant chemotherapy for patients with ovarian cancer.
First Author: Hannah Dysinger McLaughlin